Literature DB >> 14615319

WHO tries to tackle problem of counterfeit medicines in Asia.

Stephen Pincock.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14615319      PMCID: PMC1126859          DOI: 10.1136/bmj.327.7424.1126-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  In-vitro evaluation of the quality of paracetamol and co-trimoxazole tablets used in Malawi based on pharmacopoeial standards.

Authors:  Felix Khuluza
Journal:  Malawi Med J       Date:  2014-06       Impact factor: 0.875

2.  Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.

Authors:  Zohar B Weinstein; Muhammad H Zaman
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 3.  Substandard/counterfeit antimicrobial drugs.

Authors:  Theodoros Kelesidis; Matthew E Falagas
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Quality of antimalarials at the epicenter of antimalarial drug resistance: results from an overt and mystery client survey in Cambodia.

Authors:  Shunmay Yeung; Harriet L S Lawford; Patricia Tabernero; Chea Nguon; Albert van Wyk; Naiela Malik; Mikhael DeSousa; Ouk Rada; Mam Boravann; Prabha Dwivedi; Dana M Hostetler; Isabel Swamidoss; Michael D Green; Facundo M Fernandez; Harparkash Kaur
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

5.  Quantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis.

Authors:  Zohar B Weinstein; Muhammad H Zaman
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

6.  Faking it - II: Countering and preventing counterfeiting of drugs.

Authors:  G Swaminath
Journal:  Indian J Psychiatry       Date:  2009-01       Impact factor: 1.759

7.  Dangerous medicines: unproven AIDS cures and counterfeit antiretroviral drugs.

Authors:  Joseph J Amon
Journal:  Global Health       Date:  2008-02-27       Impact factor: 4.185

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.